Author

Shanna C. Yeung

University of British ColumbiaORCID 0000-0002-6459-443XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Jon StoessliD· 2 shared Jason J.S. BartoniD· 2 shared Mariya V. CherkasovaiD· 2 shared Martin J. McKeowniD· 2 shared Silke Appel‐CresswelliD· 2 shared Alisdair TayloriD· 1 shared Anna IsbergiD· 1 shared Catharine A. WinstanleyiD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

A. Jon StoesslORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintSep 12, 2026

Dopamine Agonists in Parkinson's Disease Decouple Risk-Taking from Reward-Paired Cues by Enhancing Risky Choice in Their Absence

Katherine Muksuris, Ellen Flynn, Tanya L. Feng…·Mariya V. Cherkasova

This study shows that dopamine agonists combined with levodopa increase risky choices in Parkinson's patients even without reward-paired cues.

DOI 10.64898/2026.09.05.748022

humanexperimental assay

𝕏 PostBluesky

NeuroscienceParkinsonism & Related DisordersPeer-reviewedAug 26, 2019

Dopamine replacement remediates risk aversion in Parkinson’s disease in a value-independent manner

Mariya V. Cherkasova, Jeffrey C. Corrow, Alisdair Taylor…·Jason J.S. Barton

This study shows that dopamine replacement in Parkinson’s disease patients reduces risk aversion in a value-independent manner, while also increasing sensitivity to expected values.

4 citations

humanstatistical model

𝕏 PostBluesky